科研项目详细信息
Development of a preclinical drug candidate for treatment of visceral leishmaniasis through optimisation of scaffolds identified from a phenotypic HTS screen of L. donovani axenic amastigote proliferation | |
Dr Richard Glynne | |
Genomics Institute of the Novartis Research Foundation | |
Subject:医学(综合) | |
2014至2014 | |
Source: 英国惠康基金会 | |
Link: https://wellcome.org/grant-funding/funded-people-and-projects |